Literature DB >> 28988701

Choosing the Active X: The Human Version of X Inactivation.

Barbara R Migeon1.   

Abstract

Humans and rodents differ in how they carry out X inactivation (XI), the mammalian method to compensate for the different number of X chromosomes in males and females. Evolutionary changes in staging embryogenesis and in mutations within the XI center alter the process among mammals. The mouse model of XI is predicated on X counting and subsequently choosing the X to 'inactivate'. However, new evidence suggests that humans initiate XI by protecting one X in both sexes from inactivation by XIST, the noncoding RNA that silences the inactive X. This opinion article explores the question of how the active X is protected from silencing by its own Xist locus, and the possibility of different solutions for mouse and human.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  X dosage compensation; X inactivation; autosomal repressor of XIST; single active X; species differences in X inactivation

Mesh:

Substances:

Year:  2017        PMID: 28988701     DOI: 10.1016/j.tig.2017.09.005

Source DB:  PubMed          Journal:  Trends Genet        ISSN: 0168-9525            Impact factor:   11.639


  14 in total

Review 1.  Epigenetics with special reference to the human X chromosome inactivation and the enigma of Drosophila DNA methylation.

Authors:  Deepti Deobagkar
Journal:  J Genet       Date:  2018-06       Impact factor: 1.166

2.  Directional X Chromosome Skewing of White Blood Cells from Subjects with Heterozygous Mosaicism for the Variant IRAK1 Haplotype.

Authors:  Patrick Morcillo; Yong Qin; Geber Peña; Anne C Mosenthal; David H Livingston; Zoltan Spolarics
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

Review 3.  X- and Y-Linked Chromatin-Modifying Genes as Regulators of Sex-Specific Cancer Incidence and Prognosis.

Authors:  Rossella Tricarico; Emmanuelle Nicolas; Michael J Hall; Erica A Golemis
Journal:  Clin Cancer Res       Date:  2020-07-30       Impact factor: 12.531

4.  Paircounting.

Authors:  Huy Q Nguyen; S Dean Lee; C-Ting Wu
Journal:  Trends Genet       Date:  2019-09-12       Impact factor: 11.639

5.  X-Linked IRAK1 Polymorphism is Associated with Sex-Related Differences in Polymorphonuclear Granulocyte and Monocyte Activation and Response Variabilities.

Authors:  Yong Qin; Geber Peña; Patrick Morcillo; Sukhwinder Singh; Anne C Mosenthal; David H Livingston; Zoltan Spolarics
Journal:  Shock       Date:  2020-04       Impact factor: 3.533

Review 6.  The X chromosome and sex-specific effects in infectious disease susceptibility.

Authors:  Haiko Schurz; Muneeb Salie; Gerard Tromp; Eileen G Hoal; Craig J Kinnear; Marlo Möller
Journal:  Hum Genomics       Date:  2019-01-08       Impact factor: 4.639

7.  Structure, dynamics and roX2-lncRNA binding of tandem double-stranded RNA binding domains dsRBD1,2 of Drosophila helicase Maleless.

Authors:  Pravin Kumar Ankush Jagtap; Marisa Müller; Pawel Masiewicz; Sören von Bülow; Nele Merret Hollmann; Po-Chia Chen; Bernd Simon; Andreas W Thomae; Peter B Becker; Janosch Hennig
Journal:  Nucleic Acids Res       Date:  2019-05-07       Impact factor: 16.971

8.  Long non-coding RNA XIST promotes cell proliferation and migration through targeting miR-133a in bladder cancer.

Authors:  Keqin Zhou; Jinrui Yang; Xurui Li; Wenjie Chen
Journal:  Exp Ther Med       Date:  2019-08-29       Impact factor: 2.447

Review 9.  What should we consider in the case of combined Down- and 47,XY,+i(X)(q10) Klinefelter syndromes? The unique case of a male newborn and review of the literature.

Authors:  Eva Pinti; Anna Lengyel; Gyorgy Fekete; Iren Haltrich
Journal:  BMC Pediatr       Date:  2020-01-13       Impact factor: 2.125

10.  SeXY chromosomes and the immune system: reflections after a comparative study.

Authors:  Irene Meester; Edgar Manilla-Muñoz; Rafael B R León-Cachón; Gustavo A Paniagua-Frausto; Diego Carrión-Alvarez; C Orelli Ruiz-Rodríguez; Ximena Rodríguez-Rangel; Joyce M García-Martínez
Journal:  Biol Sex Differ       Date:  2020-01-14       Impact factor: 5.027

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.